These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 15480048)
1. High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract. Perlow A; Bui C; Shreve P; Sundgren PC; Teknos TN; Mukherji SK J Comput Assist Tomogr; 2004; 28(5):704-9. PubMed ID: 15480048 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer. Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773 [TBL] [Abstract][Full Text] [Related]
3. The role of gamma-PET in the evaluation of patients with recurrent squamous cell cancer of the head and neck. Goshen E; Yahalom R; Talmi YP; Rotenberg G; Oksman Y; Zwas ST Int J Oral Maxillofac Surg; 2005 Jun; 34(4):386-90. PubMed ID: 16053847 [TBL] [Abstract][Full Text] [Related]
4. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer. Fogh SE; Kubicek GJ; Champ C; Intenzo C; Axelrod R; Keane WM; Machtay MM Am J Clin Oncol; 2012 Aug; 35(4):311-5. PubMed ID: 22772424 [TBL] [Abstract][Full Text] [Related]
5. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
6. Han EJ; O JH; Yoo IR; Kim YS; Kim MS; Kang JH; Choi WH Hell J Nucl Med; 2017; 20(2):134-140. PubMed ID: 28697190 [TBL] [Abstract][Full Text] [Related]
7. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
9. Staging of head and neck squamous cell cancer with extended-field FDG-PET. Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746 [TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma. Yi JS; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY; Roh JL J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652 [TBL] [Abstract][Full Text] [Related]
11. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT. Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818 [TBL] [Abstract][Full Text] [Related]
12. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer. Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136 [TBL] [Abstract][Full Text] [Related]
13. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Lin KJ; Lin WJ; Fu YK; Lin CY J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151 [TBL] [Abstract][Full Text] [Related]
14. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma. Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443 [TBL] [Abstract][Full Text] [Related]
15. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck. Goerres GW; Haenggeli CA; Allaoua M; Albrecht SR; Dulguerov P; Becker M; Allal AS; Lehmann W; Slosman DO Nuklearmedizin; 2000 Dec; 39(8):246-50. PubMed ID: 11189902 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma. Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135 [TBL] [Abstract][Full Text] [Related]
17. Clinical utility of Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365 [No Abstract] [Full Text] [Related]
18. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET? Brouwer J; Senft A; de Bree R; Comans EF; Golding RP; Castelijns JA; Hoekstra OS; Leemans CR Oral Oncol; 2006 Mar; 42(3):275-80. PubMed ID: 16266820 [TBL] [Abstract][Full Text] [Related]
19. Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517 [TBL] [Abstract][Full Text] [Related]